# Tonix Pharmaceuticals Holding Corp.: Form 8-K, filed Mar 18, 2026

- Company: [Tonix Pharmaceuticals Holding Corp.](/companies/tnxp.md) (CIK 1430306)
- Form: 8-K
- Filed: 2026-03-18
- Accepted by EDGAR: Mar 18, 2026, 06:01 ET
- Period: 2026-03-16
- Accession: 0001999371-26-006169
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1430306/000199937126006169/tonix-8k_031826.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1430306/000199937126006169/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1430306/000199937126006169/tonix-8k_031826.htm

Filed Mar 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001999371-26-006169. Last ingested by Listed: Nov 14, 2026, 18:37 ET. No prices; not investment advice.
